文献类型：期刊文章

作　　者：徐勇[1] 胡承[2] 杨涛[3] 时立新[4] 刘铭[5] 洪天配[6] 周智广[7] 翁建平[8] 纪立农[9] 朱大龙[10] 徐涛[11] 李小英[12] 中华医学会糖尿病学分会糖尿病基础研究与转化医学学组[13]

Xu Yong;Hu Cheng;Yang Tao;Shi Lixin;Liu Ming;Hong Tianpei;Zhou Zhiguang;Weng Jianping;Ji Linong;Zhu Dalong;Xu Tao;Li Xiaoying;Diabetes Basic Research and Translational Medicine Group of Chinese Diabetes Society(Department of Endocrinology,the Affiliated Hospital of Southwest Medical University,Luzhou 646000,China;Department of Endocrinology and Metabolism,Shanghai Jiao Tong University Affiliated 6th People′s Hospital,Shanghai Diabetes Institute,Shanghai 200233,China;Department of Endocrinology and Metabolism,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China;Department of Endocrinology and Metabolism,Affiliated Hospital of Guizhou Medical University,Guiyang 550004,China;Department of Endocrinology and Metabolism,General Hospital of Tianjin Medical University,Tianjin 300052,China;Department of Endocrinology,Peking University Third Hospital,Beijing 100191,China;Department of Metabolism and Endocrinology,the Second Xiangya Hospital,Central South University,Key Laboratory of Diabetes Immunology,Ministry of Education,National Clinical Research Center for Metabolic Diseases,Changsha 410011,China;Dapartment of Endocrinology,Institute of Endocrine and Metabolic Diseases,the First Affiliated Hospital,University of Science and Technology of China,Clinical Research Hospital of Chinese Academy of Sciences(Hefei),Hefei 230001,China;Department of Endocrinology,Peking University,People′s Hospital,Beijing 100044,China;Department of Endocrinology,Drum Tower Hospital Affiliated to Nanjing University Medical School,Nanjing 210008,China;National Laboratory of Biomacromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China,Medical Science and Technology Innovation Center,Jinan Central Hospital Affiliated to Shandong First Medical University,Jinan 250013,China;Department of Endocrinology,Zhongshan Hospital Associated Fudan University,Shanghai 200032,China;不详)

机构地区：[1]西南医科大学附属医院内分泌科,泸州646000 [2]上海市糖尿病研究所,上海市糖尿病重点实验室,上海市糖尿病临床医学中心,上海200233 [3]南京医科大学第一附属医院内分泌科,南京210029 [4]贵州医科大学附属医院内分泌代谢病科,贵阳550004 [5]天津医科大学总医院内分泌代谢科,天津300052 [6]北京大学第三医院内分泌科,北京100191 [7]中南大学湘雅二医院代谢内分泌科,糖尿病免疫学教育部重点实验室,国家代谢性疾病临床医学研究中心,长沙410011 [8]中国科学技术大学附属第一医院内分泌科中国科学技术大学内分泌代谢病研究所,中国科学院临床研究医院(合肥),合肥230001 [9]北京大学人民医院内分泌代谢科,北京100044 [10]南京大学医学院附属鼓楼医院内分泌科,南京210008 [11]中国科学院生物物理研究所大分子国家重点实验室,北京100101,山东第一医科大学附属中心医院(济南市中心医院)科创中心,济南250013 [12]复旦大学附属中山医院内分泌科,上海200032 [13]不详

出　　处：《中华糖尿病杂志》

年　　份：2022

卷　　号：14

期　　号：5

起止页码：423-432

语　　种：中文

收录情况：BDHX、BDHX2020、CAS、CSCD、CSCD2021_2022、EMBASE、IC、JST、RCCSE、SCOPUS、UPD、ZGKJHX、核心刊

摘　　要：青少年起病的成人型糖尿病(MODY)是一类特殊类型糖尿病,迄今已报道有14种MODY类型,约占糖尿病患者人数的1%~5%。MODY发病常常较为隐匿,临床上时常被漏诊。随着对MODY临床特点认识的深入以及分子生物学检测技术的迅速发展,越来越多的MODY患者被早期发现和诊断。本共识旨在帮助MODY患者早期发现、正确诊断和精准治疗,推动MODY的规范化筛查与诊治。

关 键 词：青少年起病的成人型糖尿病  筛查  诊治 共识  

分 类 号：R587.1]